Covered recipient · General Payments record
VICTORIA LEIGH TAKUBO
Physician Assistants & Advanced Practice Nursing Providers Physician Assistant Surgical
General Payments · PY2021–2024
$2,151.13
- Reported across 98 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $402.65 | 17 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Endo USA, Inc. | $104.94 | 5 |
| Galvanize Therapeutics, Inc | $73.37 | 2 |
| PFIZER INC. | $58.61 | 3 |
| ABBVIE INC. | $57.27 | 2 |
| Endo Pharmaceuticals Inc. | $49.33 | 2 |
| 180 Medical, Inc. | $25.77 | 1 |
| VERTEX PHARMACEUTICALS INCORPORATED | $17.29 | 1 |
| Astellas Pharma US Inc | $16.07 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| 180 Medical, Inc. | $25.77 | 06/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151368949 | CMS |
| ABBVIE INC. | $31.82 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108283289 | CMS |
| ABBVIE INC. | $25.45 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108283291 | CMS |
| Astellas Pharma US Inc | $16.07 | 01/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139475922 | CMS |
| Endo Pharmaceuticals Inc. | $24.95 | 02/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137021500 | CMS |
| Endo Pharmaceuticals Inc. | $24.38 | 04/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137021502 | CMS |
| Endo USA, Inc. | $19.71 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138596874 | CMS |
| Endo USA, Inc. | $24.32 | 07/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138596876 | CMS |
| Endo USA, Inc. | $15.76 | 09/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138596878 | CMS |
| Endo USA, Inc. | $21.47 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138596880 | CMS |
| Endo USA, Inc. | $23.68 | 12/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138596882 | CMS |
| Galvanize Therapeutics, Inc | $57.50 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144505314 | CMS |
| Galvanize Therapeutics, Inc | $15.87 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144505316 | CMS |
| PFIZER INC. | $16.12 | 04/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131820406 | CMS |
| PFIZER INC. | $21.44 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131856600 | CMS |
| PFIZER INC. | $21.05 | 11/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132111991 | CMS |
| VERTEX PHARMACEUTICALS INCORPORATED | $17.29 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105915022 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.